glp-1 drugs long term side effects nausea: How to handle GLP-1s' most common effect Research shows GLP-1 drugs are

Other data shows that GLP-1 agonists increase bone formation and prevent bone loss with weight loss emphasizing the fact that there is much to be learned regarding GLP-1 agonist use and musculoskeletal healing and rehabilitation

[DOI] [PubMed] 43.Facciorusso A., Ramai D., Dhar J., Samanta J., Chandan S., Gkolfakis P., Crin S.F., Maida M., Anderloni A., Boskoski I., et al

Interestingly, female participants lost more weight than male participants over the 48 weeks, achieving 28.5% and 21.9% with 12 mg, respectively

using a nationwide commercial administrative claims database between 2005 and 2021, the use of GLP-1 RAs in patients with T2DM, as compared to that of dipeptidyl peptidase IV (DPP-IV) inhibitors (gliptins), has not been shown to be associated with an increased risk of pulmonary complications after EGD [26]

What we do have is two strong signals pointing the other way

In vivo doseresponse on food intake/body weight in diet-induced obese (DIO) rats In our first preclinical experiment, we performed a dose escalation study in DIO rats to compare responses to treatment with GEP44 and Ex-4